Chong Kun Dang Kochon Foundation held a ceremony to award scholarship certificates for 2026 at Chong Kun Dang headquarters in Chungjeong-ro, Seoul, on March 3.
The foundation is operating scholarship programs worth about 3 billion won annually, including academic projects offering scholarships and free accommodation to Korean and foreign scholarship recipients, including 110 students this year.
One hundred and sixty-eight out of the selected scholarship recipients are expected to receive 1.1 billion won worth of scholarships encompassing tuitions and living costs.
Ninety-eight tuition recipients — 57 Koreans and 41 foreign students — are offered full university tuition, while each of the 70 living cost recipients is offered 500,000 won in living costs monthly.
Two hundred and thirty-five students hailing from provincial areas are offered free accommodation, including utilities fees, at a dormitory run by the foundation.
The dormitory allows free accommodation scholarship recipients to save living costs worth more than 8 million won annually. The value of the total support is converted into 1.9 billion won annually.
The Chong Kun Dang Kochon Dormitory is the first accommodation facility, being built by a civilian scholarship foundation, designed to accommodate students hailing from provincial areas, grappling with rent and jeonse issues.
The dormitory has been established at a request of Chong Kun Dang Chmn. Lee Jang-han.
The dormitory has buildings in Donggyo-dong, Mapo-gu, Hwigyeong-dong, Dongdaemun-gu, Junggok-dong, Gwangjin-gu, and Yeongdeungpo-dong, Yeongdeungpo-gu, all dense areas with Seoul’s major universities.
Kim Moon-gyeong, a scholarship recipient selected this year, said, “I appreciate the foundation for finding my growth potential and offering full support for the future, and as the scholarship is a motivation for a dream, I will be a reborn into a person who give a hope to someone else in the future by accumulating expertise in my major sector.”
Chmn. Jeong Jae-jeong of Chong Kun Dang Kochon Foundation and Chong Kun Dang Holdings President Choi Hee-nam pose with scholarship recipient students at a ceremony to award scholarship certificates for 2026 at Chong Kun Dang headquarters in Chungjeong-ro, Seoul, on Feb. 27. (Photo: Chong Kun Dang Kochon Foundation)
Chmn. Jeong Jae-jeong of Chong Kun Dang Kochon Foundation said, “The foundation’s mission is to creating an environment in which students with unlimited potential can unfurl their dreams by devoting themselves to studying without economic hardships, and we will spare no effort in providing multifaceted support so scholarship recipients can grow into gifted manpower with expertise knowledge and warm-hearted character.”
The foundation was established by the late Lee Jong-ken, the founder of Chong Kun Dang, in 1973 with the goal of returning corporate profits to society.
The scope of scholarships has been expanding to cover foreign scholarship recipients, including students from countries, such as Indonesia and Vietnam.
Chong Kun Dang is the Korean pharmaceutical industry’s largest-ever scholarship programs that have offered a combined 76.1 billion won to 10,926 students for 53 years since its foundation.
An image of Chong Kun Dang’s biosimilar of the blockbuster autoimmune disease treatment Dupixent (dupilumab).
Obtains 1st Phase Clinical Trial Approval for Dupixent Biosimilar from Europe
Chong Kun Dang received the go-ahead on Europe’s first phase clinical trial for CKD-706, the company’s biosimilar of the blockbuster autoimmune disease treatment Dupixent (dupilumab).
Chong Kun Dang said on Jan. 14 the pharmaceutical company was given the green light for the phase 1 clinical trial protocol for CKD-706 from the European Medicines Agency (EMA) and the Medicines and Healthcare Products Regulatory Agency (MHRA).
_종근당 이장한 회장.jpg)
_2026년 종근당고촌재단 장학증서 수여식02.jpg)
_듀피젠트 바이오시밀러03.jpg)
